Analysis and Commentary 5/4/18 Analysis and Commentary 5/4/18 Additional Investment = Substantial Added Value Read More Advocacy at a Glance 5/4/18 Advocacy at a Glance 5/4/18 Advocacy at a Glance Read More Analysis and Commentary 4/27/18 Analysis and Commentary 4/27/18 FY 19 -- Off to a Great Start Read More Advocacy at a Glance 4/27/18 Advocacy at a Glance 4/27/18 Advocacy at a Glance Read More Analysis and Commentary 4/20/18 Analysis and Commentary 4/20/18 The Alliance's "Ask" for FY 19 Read More Advocacy at a Glance 4/20/18 Advocacy at a Glance 4/20/18 Advocacy at a Glance Read More Analysis and Commentary 4/13/18 Analysis and Commentary 4/13/18 CBER Today and Tomorrow: Challenges and Opportunities Read More Advocacy at a Glance 4/13/18 Advocacy at a Glance 4/13/18 Advocacy at a Glance Read More Analysis and Commentary 4/6/18 Analysis and Commentary 4/6/18 A Hill Day Q&A ... Please Join Us Read More Advocacy at a Glance 4/6/18 Advocacy at a Glance 4/6/18 Advocacy at a Glance Read More Analysis and Commentary 3/23/18 Analysis and Commentary 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More Advocacy at a Glance 3/23/18 Advocacy at a Glance 3/23/18 Advocacy at a Glance Read More 3/22/18 3/22/18 Alliance Thanks Appropriators for Continued Support of FDA Read More Analysis and Commentary 3/16/18 Analysis and Commentary 3/16/18 Key CDER Priorities Need Funding Too Read More Advocacy at a Glance 3/16/18 Advocacy at a Glance 3/16/18 Advocacy at a Glance Read More Analysis and Commentary 3/11/18 Analysis and Commentary 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More Advocacy at a Glance 3/11/18 Advocacy at a Glance 3/11/18 Advocacy at a Glance Read More Advocacy at a Glance 3/3/18 Advocacy at a Glance 3/3/18 Making the Case: The Alliance's "Ask" for FY 19 Read More Advocacy at a Glance 3/3/18 Advocacy at a Glance 3/3/18 Advocacy at a Glance Read More Analysis and Commentary 2/23/18 Analysis and Commentary 2/23/18 First Impressions and Key Priorities on the Hill Read More Newer Posts Older Posts
Analysis and Commentary 5/4/18 Analysis and Commentary 5/4/18 Additional Investment = Substantial Added Value Read More
Analysis and Commentary 4/27/18 Analysis and Commentary 4/27/18 FY 19 -- Off to a Great Start Read More
Analysis and Commentary 4/20/18 Analysis and Commentary 4/20/18 The Alliance's "Ask" for FY 19 Read More
Analysis and Commentary 4/13/18 Analysis and Commentary 4/13/18 CBER Today and Tomorrow: Challenges and Opportunities Read More
Analysis and Commentary 4/6/18 Analysis and Commentary 4/6/18 A Hill Day Q&A ... Please Join Us Read More
Analysis and Commentary 3/23/18 Analysis and Commentary 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More
Analysis and Commentary 3/16/18 Analysis and Commentary 3/16/18 Key CDER Priorities Need Funding Too Read More
Analysis and Commentary 3/11/18 Analysis and Commentary 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More
Advocacy at a Glance 3/3/18 Advocacy at a Glance 3/3/18 Making the Case: The Alliance's "Ask" for FY 19 Read More
Analysis and Commentary 2/23/18 Analysis and Commentary 2/23/18 First Impressions and Key Priorities on the Hill Read More
